Current evidence and the potential role of proton beam therapy for hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is a leading cause of cancer-related death, and external beam radiation therapy has emerged as a promising approach for managing HCC. Proton beam therapy (PBT) offers dosimetric advantages over X-ray therapy, with superior physical properties known as the Bragg peak. P...
Main Authors: | Sung Uk Lee, Tae Hyun Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Association for the Study of the Liver
2023-10-01
|
Series: | Clinical and Molecular Hepatology |
Subjects: | |
Online Access: | http://e-cmh.org/upload/pdf/cmh-2023-0274.pdf |
Similar Items
-
Proton Beam Therapy for Treatment-Naïve Hepatocellular Carcinoma and Prognostic Significance of Albumin-Bilirubin (ALBI) Grade
by: Tae Hyun Kim, et al.
Published: (2022-09-01) -
Phase II Study of Hypofractionated Proton Beam Therapy for Hepatocellular Carcinoma
by: Tae Hyun Kim, et al.
Published: (2020-04-01) -
Current role of proton beam therapy in patients with hepatocellular carcinoma
by: Gyu Sang Yoo, et al.
Published: (2021-10-01) -
Proton versus photon radiotherapy for primary hepatocellular carcinoma: a propensity-matched analysis
by: Jen-Yu Cheng, et al.
Published: (2020-06-01) -
Tumor Response on Diagnostic Imaging after Proton Beam Therapy for Hepatocellular Carcinoma
by: Hikaru Niitsu, et al.
Published: (2024-01-01)